NCT05898243 Prospective Descriptive Study of Injuries Associated to Anterior Shoulder Dislocations in Patients Over 40 Years
| NCT ID | NCT05898243 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Corporacion Parc Tauli |
| Condition | Anterior Glenohumeral Dislocations |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2028-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2023-06-01 with a primary completion date of 2028-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The glenohumeral joint has the highest rate of dislocation of the whole body, due to its high mobility and the special characteristics of its anatomy. It is estimated that every year between 1-2% of the population will suffer from glenohumeral dislocation. The vast majority of studies are based on young patients under the age of 40, given that at this age they have the higher incidence and at the same time, they have higher redislocation index. However, the investigators are in front of a more active population with a longer life expectancy. That is why the cases of anterior glenohumeral dislocations are increasing in people older than 40 years. Given that most studies focus on younger patients, the investigators lack knowledge about which injuries are associated with dislocation at this age and whether these influence its clinical evolution.
Eligibility Criteria
Inclusion Criteria: * More than 40 years old * First episode of traumatic anterior gelnohumeral dislocation seen in Rx * Acceptance to be checked over 2 years * Acceptance to be submitted to TAC, NMR, EMG and Bilateral Ultrasound Exclusion Criteria: * Previous fractures in this extremity * Previous neurovascular lesions in this extremity * Other associated lesions * Cognitive alterations or dementia which prevent completing the protocols. Patients with \<14 points in Mini-mental test.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05898243 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Anterior Glenohumeral Dislocations. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05898243 currently recruiting?
Yes, NCT05898243 is actively recruiting participants. Contact the research team at msalomo@tauli.cat for enrollment information.
Where is the NCT05898243 trial being conducted?
This trial is being conducted at Sabadell, Spain.
Who is sponsoring the NCT05898243 clinical trial?
NCT05898243 is sponsored by Corporacion Parc Tauli. The trial plans to enroll 120 participants.